CN114939012A - Intravascular stent system and processing method thereof - Google Patents
Intravascular stent system and processing method thereof Download PDFInfo
- Publication number
- CN114939012A CN114939012A CN202110719542.4A CN202110719542A CN114939012A CN 114939012 A CN114939012 A CN 114939012A CN 202110719542 A CN202110719542 A CN 202110719542A CN 114939012 A CN114939012 A CN 114939012A
- Authority
- CN
- China
- Prior art keywords
- balloon
- stent
- section
- segment
- tip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
- A61F2002/9583—Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
技术领域technical field
本发明属于医疗器械技术领域,具体属于A61L技术领域,更具体涉及一种血管支架系统及其加工方法。The invention belongs to the technical field of medical devices, in particular to the technical field of A61L, and more particularly relates to a blood vessel stent system and a processing method thereof.
背景技术Background technique
目前对于血管内的弥漫性间断狭窄病变,往往是通过植入多个支架进行治疗或通过植入一个长支架完整覆盖整个病变区域。植入多个支架往往会带来多种问题,比如多个支架定位不准确;支架之间存在叠放风险;在支架与支架临接的非狭窄部分会由于支架植入的刺激以及植入后改变了非植入段的血流动力,容易造成血栓或是狭窄。通过植入一个长支架完整覆盖整个病变区域也会带来多种多样的问题,比如病变较长血管往往是由近端至末端为一个锥形慢慢变窄的结构,但是长支架会是一种近端到远端均匀直径的扩张的结构,所以容易导致远端血管过度撕裂,容易引发支架内再狭窄,并且由于现有的长支架是一个均匀结构,所以病变远端较小的狭窄或是细小血管会受到与病变近端相同的支架结构带来的强支撑性,容易对远端病变造成更大的刺激引发支架内再狭窄。Currently, diffuse intermittent stenotic lesions in blood vessels are often treated by implanting multiple stents or by implanting a long stent to completely cover the entire lesion area. Implanting multiple stents often brings a variety of problems, such as inaccurate positioning of multiple stents; there is a risk of stacking between stents; non-stenotic parts of stents adjacent to stents may be stimulated by stent implantation and post-implantation. Changes in the hemodynamics of the non-implanted segment are likely to cause thrombosis or stenosis. Implanting a long stent to completely cover the entire lesion area will also bring a variety of problems. For example, the long blood vessels of the lesion are often a tapered structure that gradually narrows from the proximal end to the end, but the long stent will be a It is a dilated structure with a uniform diameter from proximal to distal, so it is easy to cause excessive tearing of distal vessels and in-stent restenosis. Since the existing long stent is a uniform structure, the smaller stenosis at the distal end of the lesion is likely to occur. Or the small blood vessels will be strongly supported by the same stent structure as the proximal end of the lesion, which is likely to cause greater stimulation to the distal lesion and cause in-stent restenosis.
现亟需一种具有不同支撑强度的支架,应用在弥漫性间断狭窄病变的治疗中。There is an urgent need for stents with different supporting strengths, which can be used in the treatment of diffuse intermittent stenotic lesions.
发明内容SUMMARY OF THE INVENTION
为了下面的详细描述的目的,应当理解,本发明可采用各种替代的变化和步骤顺序,除非明确规定相反。For the purposes of the following detailed description, it should be understood that the present invention may employ various alternative variations and sequences of steps, unless expressly stated to the contrary.
为解决上述技术问题,本发明的第一个方面提供了一种血管支架系统,包括支架,所述支架的径向抗挤压力自近端向远端逐渐降低;球囊输送系统,所述球囊输送系统包括筒状的球囊,连接于球囊一端的尖端,连接于球囊另一端的外管,连接于尖端另一端的内管,所述内管贯穿于球囊和外管的中部并与尖端、球囊和外管构成压力通道,所述球囊的顺应性自近端向远端逐渐增加;当球囊收缩时所述支架压握于球囊的外壁上,当球囊扩张时所述支架与球囊相脱离。In order to solve the above technical problems, a first aspect of the present invention provides a vascular stent system, including a stent, the radial compression resistance of the stent is gradually reduced from the proximal end to the distal end; a balloon delivery system, the The balloon delivery system comprises a cylindrical balloon, a tip connected to one end of the balloon, an outer tube connected to the other end of the balloon, and an inner tube connected to the other end of the tip, the inner tube running through the balloon and the outer tube. The middle part forms a pressure channel with the tip, the balloon and the outer tube, and the compliance of the balloon gradually increases from the proximal end to the distal end; when the balloon contracts, the stent is pressed against the outer wall of the balloon, and when the balloon is deflated, the stent is pressed against the outer wall of the balloon. The stent disengages from the balloon during expansion.
支架通过球囊输送系统将其送至病变处,并通过对球囊所形成的压力通道中充入气体或液体,实现球囊的扩张,从而使支架扩张,并支撑于血管的内壁上,实现血管的扩张与支撑。发明人将支架设计成其径向抗挤压力自近端向远端逐渐降低的结构,当该支架用于治疗血管内的弥漫性间断狭窄病变时,由于血管呈锥形且逐渐变窄的结构,对于血管的近端由于较大的直径和较大的血流动力,需要支架提供较强的支撑性,即较大的径向抗挤压力,对于血管的远端由于较小的直径和较小的血流动力,需要支架提供较弱的支撑性,即较弱的径向抗挤压力。本技术方案中发明人将支架自近端向远端的支撑强度设计为逐渐降低的结构,既能够满足血管近端所需要的较强的支撑强度,又能够满足血管远端所需要的较弱的支撑强度。且球囊的顺应性自近端向远端逐渐增加,球囊与支架适配,能够保证支架的每一段实现较好的扩张与支撑。The stent is delivered to the lesion through the balloon delivery system, and the balloon is filled with gas or liquid through the pressure channel formed by the balloon to realize the expansion of the balloon, so that the stent is expanded and supported on the inner wall of the blood vessel to achieve Dilation and support of blood vessels. The inventor designed the stent to have a structure in which its radial anti-compression force gradually decreases from the proximal end to the distal end. When the stent is used for the treatment of diffuse intermittent stenosis in the blood vessel, due to the tapered and gradually narrowing of the blood vessel. Structure, for the proximal end of the blood vessel, due to the larger diameter and greater hemodynamics, the stent needs to provide strong support, that is, a larger radial anti-extrusion force, for the distal end of the blood vessel due to the smaller diameter and smaller hemodynamics, the stent needs to provide weaker support, that is, weaker radial anti-extrusion force. In this technical solution, the inventor designed the support strength of the stent from the proximal end to the distal end to be a gradually decreasing structure, which can not only satisfy the strong supporting strength required by the proximal end of the blood vessel, but also meet the weaker supporting strength required by the distal end of the blood vessel. support strength. In addition, the compliance of the balloon gradually increases from the proximal end to the distal end, and the balloon is adapted to the stent, which can ensure that each section of the stent achieves better expansion and support.
作为一种优选的技术方案,所述支架的径向抗挤压力自近端向远端逐渐降低的方式为线性渐变式降低或阶段性台阶式降低中的一种。As a preferred technical solution, the manner in which the radial compression resistance force of the stent is gradually reduced from the proximal end to the distal end is one of linear gradual reduction or step-by-step reduction.
作为一种优选的技术方案,所述球囊的顺应性自近端向远端逐渐降低的方式为线性渐变式降低或阶段性台阶式降低中的一种。As a preferred technical solution, the manner in which the compliance of the balloon gradually decreases from the proximal end to the distal end is one of a linear gradual decrease or a stepwise decrease.
作为一种优选的技术方案,所述支架包括多个支撑梁、连接支撑梁的连接杆,所述支撑梁为由凸峰和凹谷重复延伸形成的波浪状。As a preferred technical solution, the bracket includes a plurality of supporting beams and connecting rods connecting the supporting beams, and the supporting beams are in a wave shape formed by repeated extensions of convex peaks and concave valleys.
作为一种优选的技术方案,所述支架由M段连接而成,其中M≥1,所述球囊是由N段连接而成,其中M=N,对于所述支架的每一段球囊的相对应处能够实现球囊收缩时支架压握于球囊的外壁上,球囊扩张时支架与球囊相脱离。As a preferred technical solution, the stent is formed by connecting M sections, wherein M≥1, and the balloon is formed by connecting N sections, wherein M=N, for each section of the stent, the balloon is Correspondingly, the stent can be pressed and held on the outer wall of the balloon when the balloon is deflated, and the stent can be separated from the balloon when the balloon is expanded.
作为一种优选的技术方案,所述球囊N段中的每一段的顺应性均≥105%。As a preferred technical solution, the compliance of each of the N segments of the balloon is greater than or equal to 105%.
作为一种优选的技术方案,所述支架由3段连接而成,自近端到远端分别为第一段支架、第二段支架和第三段支架,所述第一段支架的径向抗挤压力>1.5N/mm,所述第二段支架的径向抗挤压力在1.0N/mm-1.5N/mm,所述第三段支架的径向抗挤压力<1.0N/mm。As a preferred technical solution, the stent is formed by connecting three sections. From the proximal end to the distal end, there are a first section of stent, a second section of stent and a third section of stent. The radial direction of the first section of stent is Anti-extrusion force>1.5N/mm, the radial anti-extrusion force of the second-stage stent is 1.0N/mm-1.5N/mm, and the radial anti-extrusion force of the third-stage stent<1.0N /mm.
作为一种优选的技术方案,所述第一段支架的支撑梁的梁宽在150-200um,凸峰和凹谷的弧度在2Π/3-5Π/6,所述第二段支架的支撑梁的梁宽在100-150um,凸峰和凹谷的弧度在Π/2-2Π/3,所述第三段支架的支撑梁的梁宽在50-100um,凸峰和凹谷的弧度在Π/3-Π/2。As a preferred technical solution, the beam width of the support beam of the first section of the bracket is 150-200um, the curvature of the peaks and valleys is 2Π/3-5Π/6, and the support beam of the second section of the bracket is 150-200um. The beam width is 100-150um, the radian of the convex peaks and valleys is Π/2-2Π/3, the beam width of the support beam of the third bracket is 50-100um, and the radians of the convex peaks and valleys are Π /3-Π/2.
本技术方案中所述的径向抗挤压力的测试标准为ISO25539-2,所述径向抗挤压力的大小能够表征支架的支撑强度。The test standard of the radial anti-extrusion force described in this technical solution is ISO25539-2, and the magnitude of the radial anti-extrusion force can represent the support strength of the stent.
发明人发现通过调整支撑梁的梁宽的范围和凸峰和凹谷的弧度,能够改变支架的支撑强度,但是梁宽太大会降低支架在球囊上的可压握性,梁宽太小不能起到对血管的支撑和扩张性,凸峰和凹谷的弧度越大,对血管具有越好的支撑性,但是在将支架输送至病变处时,容易发生支架脱落的现象,凸峰和凹谷的弧度较小时会大幅降低支架的支撑强度,增大支架在血管中的运输阻力。发明人发现通过设计支架不同部分的梁宽和凸峰和凹谷的弧度,能够使支架在不同的长度段实现不同的支撑性,从而能够应用到弥漫性间断狭窄病变中,对不同的病变部位起到不同的支撑力。The inventor found that the support strength of the stent can be changed by adjusting the range of the beam width of the support beam and the curvature of the peaks and valleys. However, if the beam width is too large, the crimpability of the stent on the balloon will be reduced. The greater the curvature of the peaks and valleys, the better the support for the blood vessels, but when the stent is delivered to the lesion, the stent is prone to fall off, and the curvature of the peaks and valleys is relatively high. If it is too small, the supporting strength of the stent will be greatly reduced, and the transportation resistance of the stent in the blood vessel will be increased. The inventors found that by designing the beam width and the curvature of the peaks and valleys of different parts of the stent, the stent can achieve different support in different lengths, so that it can be applied to diffuse intermittent stenotic lesions, and can be used for different lesions. have different supports.
作为一种优选的技术方案,所述球囊是由3段连接而成,其中自近端向远端依次为第一段球囊、第二段球囊和第三段球囊,其中第一段球囊的长度与第一段支架的长度相同,第二段球囊的长度与第二段支架的长度相同,第三段球囊的长度与第三段支架的长度相同,所述第一段球囊的顺应性在105%-110%,第二段球囊的顺应性在118%-130%,第三段球囊的顺应性大于130%。As a preferred technical solution, the balloon is formed by connecting three sections, wherein from the proximal end to the distal end are the first section of the balloon, the second section of the balloon and the third section of the balloon, wherein the first section of the balloon The length of the segment balloon is the same as the length of the first segment of the stent, the length of the second segment of the balloon is the same as the length of the second segment of the stent, and the length of the third segment of the balloon is the same as the length of the third segment of the stent. The compliance of the segment balloon is 105%-110%, the compliance of the second segment balloon is 118%-130%, and the compliance of the third segment balloon is greater than 130%.
球囊的顺应性=ΦDRBP/ΦDNormal,其中ΦDRBP为球囊额度压力下的直径,mm;其中ΦDNormal为球囊名义压力下的直径,mm。The compliance of the balloon = ΦD RBP /ΦD Normal , where ΦD RBP is the diameter of the balloon under nominal pressure, mm; where ΦD Normal is the diameter of the balloon under nominal pressure, mm.
作为一种优选的技术方案,所述第一段球囊的材料选自聚醚嵌段聚酰胺、热塑性聚氨酯弹性体、硅酸凝胶、热塑性弹性体TPE/TPR和聚氨酯中的一种。As a preferred technical solution, the material of the first-stage balloon is selected from one of polyether block polyamide, thermoplastic polyurethane elastomer, silicic acid gel, thermoplastic elastomer TPE/TPR and polyurethane.
作为一种优选的技术方案,所述第二段球囊的的材料选自PA12、聚醚嵌段聚酰胺和聚对苯二甲酸乙二醇酯中的一种。As a preferred technical solution, the material of the second section of the balloon is selected from one of PA12, polyether block polyamide and polyethylene terephthalate.
作为一种优选的技术方案,所述第三段球囊的的材料选自PA11、PA12、聚对苯二甲酸乙二醇酯和聚醚嵌段聚酰胺中的一种。As a preferred technical solution, the material of the third-stage balloon is selected from one of PA11, PA12, polyethylene terephthalate and polyether block polyamide.
发明人通过选择球囊不同长度段的材料,使球囊对应支架的不同的长度段处具有不同的顺应性,即不同的扩张能力,使支撑强度不同的每段支架都具有较好的扩张性。By selecting the materials of different length sections of the balloon, the inventors make the balloon corresponding to different length sections of the stent have different compliances, that is, different expansion capabilities, so that each section of the stent with different supporting strengths has better expandability. .
作为一种优选的技术方案,所述球囊的一端通过第一锥形过渡端与尖端相连接、另一端通过第二锥形过渡端与外管相连接,所述第一锥形过渡端与球囊之间形成的夹角等于或不等于第二锥形过渡端与球囊之间形成的夹角。As a preferred technical solution, one end of the balloon is connected to the tip through a first conical transition end, and the other end is connected to the outer tube through a second conical transition end, and the first conical transition end is connected to the outer tube. The angle formed between the balloons may or may not be equal to the angle formed between the second tapered transition end and the balloon.
本发明所述的第二个方面提供了所述的血管支架系统的制备方法,至少包括以下步骤:The second aspect of the present invention provides the preparation method of the vascular stent system, which at least includes the following steps:
(1)球囊输送系统的制备;(1) Preparation of balloon delivery system;
(2)支架的制备;(2) Preparation of stents;
(3)将支架压握于球囊上。(3) Press and hold the stent on the balloon.
有益效果:Beneficial effects:
本技术方案中发明人通过将支架自近端至远端处的支撑强度设置为逐渐减小的结构,既能够满足血管近端所需要的较强的支撑强度,又能够满足血管远端所需要的较弱的支撑强度。既可以避免在治疗血管内的弥漫性间断狭窄病变时,放置多个支架出现结构重叠的情况,又能够避免在血管的整个病变处都提供相同的支撑强度,使血管过度撕裂,引发支架内再狭窄的问题。并且发明人通过设置球囊上不同的顺应性,使球囊对应不同的支架时,具有不同的顺应性,从而实现支架的各个段的均匀扩张,使支架在血管内具有较好的支撑性。In this technical solution, the inventors set the supporting strength of the stent from the proximal end to the distal end to a gradually decreasing structure, which can not only satisfy the strong supporting strength required by the proximal end of the blood vessel, but also meet the requirements of the distal end of the blood vessel. weaker support strength. It can not only avoid the overlapping structure of multiple stents when placing multiple stents in the treatment of diffuse intermittent stenosis lesions in the blood vessels, but also avoid providing the same support strength in the entire lesions of the blood vessels, causing excessive tearing of the blood vessels and causing stents. The problem of restenosis. In addition, the inventors set different compliances on the balloon, so that the balloons have different compliances when corresponding to different stents, so as to achieve uniform expansion of each segment of the stent, so that the stent has better support in the blood vessel.
附图说明Description of drawings
图1为实施例1中的球囊输送系统的整体结构示意图。FIG. 1 is a schematic diagram of the overall structure of the balloon delivery system in Example 1. FIG.
图2为实施例1中的第一段支架的局部结构示意图。FIG. 2 is a schematic diagram of the partial structure of the first-stage stent in Example 1. FIG.
1-球囊、2-外管、3-第二锥形过渡端、4-第一段球囊、5-第二段球囊、6-第三段球囊、7-第一锥形过渡端、8-尖端、9-内管、10-支撑梁、11-连接杆、12-凹谷、13-凸峰。1-Balloon, 2-Outer tube, 3-Second tapered transition end, 4-First segment balloon, 5-Second segment balloon, 6-Third segment balloon, 7-First tapered transition end, 8-tip, 9-inner tube, 10-support beam, 11-connecting rod, 12-valley, 13-convex peak.
具体实施方式Detailed ways
实施例1Example 1
一种血管支架系统,包括支架和用于运输支架的球囊输送系统。所述支架包括多个支撑梁10、连接支撑梁10的连接杆11,所述支撑梁10为由凸峰13和凹谷12重复延伸形成的波浪状。所述支架自近端到远端依次包括第一段支架、第二段支架和第三段支架,所述支架的材料为聚乳酸,所述第一段支架、第二段支架和第三段支架的长度比在1:1:1,如图2所示,所述第一段支架的支撑梁10的梁宽在150um,凸峰13和凹谷12的弧度在3Π/4,所述第二段支架的支撑梁的梁宽在120um,凸峰和凹谷的弧度在7Π/12,所述第三段支架的支撑梁的梁宽在90um,凸峰和凹谷的弧度在5Π/12。根据测试标准为ISO25539-2的方法测试第一段支架的径向抗挤压力在1.7N/mm,第二段支架的向抗挤压力在1.4N/mm,第三段支架的向抗挤压力在0.9N/mm。通过设置每段支架中不同的梁宽和弧度,实现支架不同段具有不同的支撑性。A vascular stent system includes a stent and a balloon delivery system for transporting the stent. The bracket includes a plurality of supporting
如图1所示,所述球囊输送系统包括筒状的球囊1,连接于球囊1一端的尖端8,连接于球囊1另一端的外管2,连接于尖端8另一端的内管9,所述内管9贯穿于球囊1和外管2的中部并与尖端8、球囊1和外管2构成压力通道,所述球囊1的顺应性自近端向远端逐渐增加;当球囊1收缩时所述支架压握于球囊1的外壁上,当球囊1扩张时所述支架与球囊1相脱离。在体外和运输过程中支架与球囊1通过压握的方式相结合,当通过球囊1将支架运至病变处时,通过对球囊1中充入气体,提高球囊1中的压力,使球囊1和支架实现扩张,从而使支架脱离球囊1,对血管内壁形成支撑。As shown in FIG. 1 , the balloon delivery system includes a cylindrical balloon 1 , which is connected to a tip 8 at one end of the balloon 1 , an outer tube 2 connected to the other end of the balloon 1 , and an inner tube 2 connected to the other end of the tip 8 . Tube 9, the inner tube 9 runs through the middle of the balloon 1 and the outer tube 2 and forms a pressure channel with the tip 8, the balloon 1 and the outer tube 2, and the compliance of the balloon 1 gradually increases from the proximal end to the distal end. Increase; when the balloon 1 is deflated, the stent is pressed against the outer wall of the balloon 1 , and when the balloon 1 is expanded, the stent is separated from the balloon 1 . In vitro and during transportation, the stent is combined with the balloon 1 by crimping. When the stent is transported to the lesion through the balloon 1, the balloon 1 is filled with gas to increase the pressure in the balloon 1. The balloon 1 and the stent are expanded, so that the stent is separated from the balloon 1 to form support for the inner wall of the blood vessel.
所述球囊是由3段连接而成,其中自近端向远端依次为第一段球囊4、第二段球囊5和第三段球囊6,其中将支架和球囊1之间进行压握时,第一段球囊4与第一段支架相对应且长度相同,第二段球囊5与第二段支架相对应且长度相同,第三段球囊6与第三段支架相对应且长度相同,所述第一段球囊4的顺应性在108%,第二段球囊5的顺应性在125%,第三段球囊6的顺应性在132%。所述第一段球囊4的材料为PA12,所述第二段球囊5的材料为聚对苯二甲酸乙二醇酯,所述第三段球囊6的材料为聚醚嵌段聚酰胺。The balloon is connected by 3 sections, wherein from the proximal end to the distal end are the first section balloon 4, the
球囊的顺应性=ΦDRBP/ΦDNormal,其中ΦDRBP为球囊额度压力下的直径,mm;其中ΦDNormal为球囊名义压力下的直径,mm。The compliance of the balloon = ΦD RBP /ΦD Normal , where ΦD RBP is the diameter of the balloon under nominal pressure, mm; where ΦD Normal is the diameter of the balloon under nominal pressure, mm.
所述球囊1的一端通过第一锥形过渡端7与尖端8相连接、另一端通过第二锥形过渡端3与外管2相连接,所述第一锥形过渡端7与球囊1之间形成的夹角等于第二锥形过渡端3与球囊1之间形成的夹角,其中夹角为155°。第一锥形过渡端7、第二锥形过渡端3与尖端8之间的夹角较大时,能够提高球囊在血管中的运输顺畅性。One end of the balloon 1 is connected to the tip 8 through a first tapered transition end 7, and the other end is connected to the outer tube 2 through a second tapered
本实施例的第二个方面提供了所述的血管支架系统的制备方法,包括以下步骤:The second aspect of the present embodiment provides the preparation method of the vascular stent system, comprising the following steps:
(1)将第一段球囊、第二段球囊和第三段球囊分别吹塑成型后,通过激光焊接的方式将第一段球囊、第二段球囊和第三段球囊焊接成为整体球囊,之后将尖端、内管和外管与球囊相焊接成型;(1) After blow molding the first, second and third balloons respectively, the first, second and third balloons are welded by laser welding. Welding to form an integral balloon, and then welding the tip, inner tube and outer tube to the balloon to form;
(2)将第一段支架、第二段支架和第三段支架分别注塑成型后通过激光焊接成为整体支架;(2) The first-stage support, the second-stage support and the third-stage support are respectively injection-molded to form an integral support by laser welding;
(3)参照专利申请号为201380057836.9中的方法将支架压握于球囊上。(3) Refer to the method in Patent Application No. 201380057836.9 to crimp the stent on the balloon.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110719542.4A CN114939012A (en) | 2021-06-28 | 2021-06-28 | Intravascular stent system and processing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110719542.4A CN114939012A (en) | 2021-06-28 | 2021-06-28 | Intravascular stent system and processing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114939012A true CN114939012A (en) | 2022-08-26 |
Family
ID=82905963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110719542.4A Pending CN114939012A (en) | 2021-06-28 | 2021-06-28 | Intravascular stent system and processing method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114939012A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042278A1 (en) * | 1997-03-25 | 1998-10-01 | Jang G David | Intravascular stent |
EP0876805A2 (en) * | 1997-05-07 | 1998-11-11 | Todd H. Turnland | Intravascular stent and stent delivery system for ostial vessel obstructions |
US20070270935A1 (en) * | 2006-05-18 | 2007-11-22 | Abbott Laboratories | Dual balloon catheter and deployment of same |
CN102131471A (en) * | 2008-07-02 | 2011-07-20 | 安乔斯里德公司 | Balloon catheter system and methods of use thereof |
CN105050550A (en) * | 2012-10-04 | 2015-11-11 | 艾博特心血管系统公司 | Method of uniform crimping and expansion of medical devices |
CN105662668A (en) * | 2016-01-14 | 2016-06-15 | 江苏大学 | Conical balloon |
CN106880428A (en) * | 2017-03-28 | 2017-06-23 | 上海百心安生物技术有限公司 | A kind of bioabsorbable stent system and method |
CN216933628U (en) * | 2021-06-28 | 2022-07-12 | 上海百心安生物技术股份有限公司 | Blood vessel support system |
-
2021
- 2021-06-28 CN CN202110719542.4A patent/CN114939012A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042278A1 (en) * | 1997-03-25 | 1998-10-01 | Jang G David | Intravascular stent |
EP0876805A2 (en) * | 1997-05-07 | 1998-11-11 | Todd H. Turnland | Intravascular stent and stent delivery system for ostial vessel obstructions |
US20070270935A1 (en) * | 2006-05-18 | 2007-11-22 | Abbott Laboratories | Dual balloon catheter and deployment of same |
CN102131471A (en) * | 2008-07-02 | 2011-07-20 | 安乔斯里德公司 | Balloon catheter system and methods of use thereof |
CN105050550A (en) * | 2012-10-04 | 2015-11-11 | 艾博特心血管系统公司 | Method of uniform crimping and expansion of medical devices |
CN105662668A (en) * | 2016-01-14 | 2016-06-15 | 江苏大学 | Conical balloon |
CN106880428A (en) * | 2017-03-28 | 2017-06-23 | 上海百心安生物技术有限公司 | A kind of bioabsorbable stent system and method |
CN216933628U (en) * | 2021-06-28 | 2022-07-12 | 上海百心安生物技术股份有限公司 | Blood vessel support system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220168120A1 (en) | System and method for treating biological vessels | |
US6423089B1 (en) | Vascular endoprosthesis and method | |
US7666342B2 (en) | Method of manufacturing a stent from a polymer tube | |
KR101439569B1 (en) | Stent and stent delivery device | |
CN113813079B (en) | Delivery device for a balloon expandable endoprosthesis | |
US20140081372A1 (en) | Stent with retention protrusions formed during crimping | |
CN106794061B (en) | Pancreatic duct stent with drainage features | |
US20090234283A1 (en) | Cutting Balloon With Connector and Dilation Element | |
JP2006502801A (en) | Expansion control type balloon | |
JP2016538947A (en) | Tapered implantable device and method of manufacturing such a device | |
US20100174357A1 (en) | Vascular Prosthesis of Varying Flexibility | |
CN216933628U (en) | Blood vessel support system | |
CN102813566A (en) | Coronary stent | |
CN114939012A (en) | Intravascular stent system and processing method thereof | |
CN105142580A (en) | Flexible stent | |
CN105796208B (en) | Intravascular stent with circumferential support bar | |
US20230372132A1 (en) | Stent and stent delivery system | |
JP6461539B2 (en) | balloon | |
WO2004060469A1 (en) | Balloon catheter with a compression member for balloon bonding | |
CN107550611B (en) | Vascular stent | |
KR102339672B1 (en) | Coated Stent and Manufacturing Method for the Same | |
CN217119105U (en) | Bifurcated sacculus | |
KR101015329B1 (en) | Surgical stent | |
US9717608B2 (en) | Expandable devices | |
JP2019122556A (en) | Stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |